A deep learning platform to assess drug proarrhythmia risk. Serrano R, Feyen DAM, Bruyneel AAN, Hnatiuk AP, et al. Cell Stem Cell 2022 Dec 18:S1934-5909(22)00486.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Serrano R, Feyen DAM, Bruyneel AAN, Hnatiuk AP, et al. A deep learning platform to assess drug proarrhythmia risk. Cell Stem Cell 2022 Dec 18:S1934-5909(22)00486.
PMID: 36563695